Krista Fogarty's most recent trade in Lipocine Inc was a trade of 5,943 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 23, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lipocine Inc | Fogarty Krista | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 5,943 | 19,460 | - | - | Stock Option (Right to Buy) | |
Lipocine Inc | Krista Fogarty | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 991 | 1,727 (0%) | 0% | 0 | Common Stock | |
Lipocine Inc | Krista Fogarty | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2022 | 91,850 | 229,850 | - | - | Stock Option (Right to Buy) | |
Lipocine Inc | Krista Fogarty | Principal Accounting Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 17 May 2022 | 12,500 | 12,500 (0%) | 0% | 0.9 | 10,750 | Common Stock |